Xerion Healthcare Limited
Private Limited Company · Southampton
LiquidationUnited KingdomIncorporated 2015Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2023-03-31
IXBRL · 167 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2023-03-31
IXBRL · 167 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2022-04-01 to 2023-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 108
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0014_09490964_20230331
- Source archive
- Accounts_Monthly_Data-May2023.zip
Accounts to 2022-03-31
IXBRL · 154 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2022-03-31
IXBRL · 154 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2021-04-01 to 2022-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 96
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0106_09490964_20220331
- Source archive
- Accounts_Monthly_Data-May2022.zip
Accounts to 2021-03-31
IXBRL · 158 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2021-03-31
IXBRL · 158 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2020-04-01 to 2021-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 100
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0091_09490964_20210331
- Source archive
- Accounts_Monthly_Data-June2021.zip
Accounts to 2020-03-31
IXBRL · 122 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2020-03-31
IXBRL · 122 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2019-04-01 to 2020-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 61
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0081_09490964_20200331
- Source archive
- Accounts_Monthly_Data-August2020.zip
Accounts to 2019-03-31
IXBRL · 90 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2019-03-31
IXBRL · 90 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2018-04-01 to 2019-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 38
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0067_09490964_20190331
- Source archive
- Accounts_Monthly_Data-June2019.zip
Accounts to 2018-03-31
IXBRL · 44 source facts · 12 selected values
Not assessedlegacy record
Accounts to 2018-03-31
IXBRL · 44 source facts · 12 selected values
Not assessed
legacy record
- Reporting period
- 2017-04-01 to 2018-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0056_09490964_20180331
- Source archive
- Accounts_Monthly_Data-July2018.zip
Accounts to 2016-03-31
IXBRL · 48 source facts · 5 selected values
Not assessedlegacy record
Accounts to 2016-03-31
IXBRL · 48 source facts · 5 selected values
Not assessed
legacy record
- Reporting period
- 2015-03-16 to 2016-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 7
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0032_09490964_20160331
- Source archive
- Accounts_Monthly_Data-July2016.zip
Registered details
09490964- Status
- Liquidation
- Type
- Private Limited Company
- Incorporated
- 2015-03-16
- Dissolved
- 2026-10-07
- Jurisdiction
- —
- Registered office
- C/O JAMES COWPER KRESTON, THE WHITE BUILDING, SOUTHAMPTON, SO15 2NP
Classification
1 SIC codes23103
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
4 SH01-derived rounds2023-11-22
£32,000 raised
£219,980 estimated post-money
2023-06-14
£30,000 raised
£162,980 estimated post-money
2022-11-15
£100,000 raised
£132,980 estimated post-money
2021-11-03
£225,000 raised
£865,232 estimated post-money
Research and innovation
7 matched grantsHarnessing SMALPs for Targeted Drug Delivery: A Multi-Modal ExplorationActiveBBSRC · Studentship · 2022-10-02 – 2026-09-29 · with 1 other participant£0whole project
Harnessing SMALPs for Targeted Drug Delivery: A Multi-Modal ExplorationActive
BBSRC · Studentship · 2022-10-02 – 2026-09-29 · with 1 other participant
£0
whole project
University of WarwickleadXerion Healthcare Ltd
Treatment of resected brain tumour beds using nanoparticle enhanced radiotherapyLeadInnovate UK · Collaborative R&D · 2022-10-01 – 2024-03-31 · with 1 other participant£202,530awarded
Treatment of resected brain tumour beds using nanoparticle enhanced radiotherapyLead
Innovate UK · Collaborative R&D · 2022-10-01 – 2024-03-31 · with 1 other participant
£202,530
awarded
Xerion Healthcare Limitedlead£202,530
Intratumoral injection of nanoparticles for cancer treatment - translation to clinical practiceLeadInnovate UK · Study · 2020-12-01 – 2021-11-30 · with 2 other participants£57,065awarded
Intratumoral injection of nanoparticles for cancer treatment - translation to clinical practiceLead
Innovate UK · Study · 2020-12-01 – 2021-11-30 · with 2 other participants
£57,065
awarded
Xerion Healthcare Limitedlead£57,065
Mathematical modelling of nanoparticle transport through tumours for application in radiotherapyEPSRC · Studentship · 2019-09-30 – 2023-09-29 · with 1 other participant£0whole project
Mathematical modelling of nanoparticle transport through tumours for application in radiotherapy
EPSRC · Studentship · 2019-09-30 – 2023-09-29 · with 1 other participant
£0
whole project
Imperial College LondonleadXerion Healthcare Ltd
Oxilia - Towards clinical translation of nanoparticle enhanced radiotherapy for inoperable and difficult to treat cancersLead
Innovate UK · Collaborative R&D · 2019-09-01 – 2022-11-30
£875,715
awarded
A 'bridge to cure' for stratified cancer patients, using a novel, precision radiotherapy system.Innovate UK · Feasibility Studies · 2018-12-01 – 2019-11-30 · with 1 other participant£50,708awarded
A 'bridge to cure' for stratified cancer patients, using a novel, precision radiotherapy system.
Innovate UK · Feasibility Studies · 2018-12-01 – 2019-11-30 · with 1 other participant
£50,708
awarded
Xerion Healthcare Limited£50,708
Nanoparticle Semiconductor Devices for Pancreatic Cancer TreatmentLead
Innovate UK · Collaborative R&D · 2017-01-01 – 2018-08-31
£240,425
awarded